United States · FDA National Drug Code directory
Taytulla
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0023-5862_031c2733-dbb1-443e-a5ec-4ce36d995402
- Product NDC
- 0023-5862
- Form
- KIT
- Composition / generic term
- norethindrone acetate and ethinyl estradiol, and ferrous fumarate
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160501
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (0023-5862-29) / 1 KIT in 1 BLISTER PACK · 0023-5862-29
- 5 CARTON in 1 TRAY (0023-5862-30) / 1 BLISTER PACK in 1 CARTON (0023-5862-28) / 1 KIT in 1 BLISTER PACK · 0023-5862-30
- 6 CARTON in 1 TRAY (0023-5862-31) / 6 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK · 0023-5862-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →